Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived stem cell injection for facial skin rejuvenation
TCTR20251021001Phase 2Not yet recruiting
- Sponsor
- Medeze
- Start
- Oct 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of autologous adipose-derived mesenchymal stromal cells in cutaneous aging, sponsored by Medeze. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
cutaneous aging
Beyond the preview
Go deeper on TCTR20251021001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251021001.